Published in P T on April 01, 2013
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA (1998) 5.16
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
Clinical practice. Herpes zoster. N Engl J Med (2002) 4.72
Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med (1996) 4.36
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ (2000) 3.40
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2002) 3.21
Herpes zoster and human immunodeficiency virus infection. J Infect Dis (1992) 3.04
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain (2001) 2.98
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain (1999) 2.77
Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis (2005) 2.74
Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician (2002) 2.34
Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology (1998) 2.30
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis (2007) 2.19
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16
Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis (2004) 2.14
The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10
Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract (2002) 2.08
A 70-year-old woman with shingles: review of herpes zoster. JAMA (2009) 2.07
Incidence of herpes zoster, 1997-2002. Epidemiol Infect (2005) 2.02
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine (2007) 2.01
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Population-based studies of varicella complications. Pediatrics (1986) 1.90
Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology (2004) 1.84
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med (2006) 1.74
Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology (1995) 1.73
Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis (2008) 1.70
Pain and its persistence in herpes zoster. Pain (1996) 1.68
Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med (1988) 1.68
Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol (2000) 1.63
Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc (2011) 1.62
Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol (2003) 1.61
Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med (2001) 1.60
Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med (1986) 1.50
Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ (2004) 1.45
Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain (1999) 1.45
The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage (1997) 1.44
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42
Recent advances in varicella-zoster virus infection. Ann Intern Med (1999) 1.41
Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol (2006) 1.40
The natural history of shingles. Events associated with reactivation of varicella-zoster virus. J R Coll Gen Pract (1970) 1.32
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccin (2010) 1.32
Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol (1997) 1.31
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol (2006) 1.31
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain (1999) 1.28
Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain (2003) 1.26
Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain. J Infect Dis (1998) 1.25
Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol (2007) 1.24
Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis (2008) 1.21
Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol (1987) 1.19
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2011) 1.17
Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis (1998) 1.16
The burden of herpes zoster and postherpetic neuralgia in the United States. J Am Osteopath Assoc (2007) 1.14
The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13
Herpes zoster and postherpetic neuralgia: past, present and future. Pain Res Manag (2009) 1.10
Herpes zoster: family history and psychological stress-case-control study. J Clin Virol (2012) 1.09
Zoster in patients infected with HIV: a review. Am J Med Sci (2001) 1.08
Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J Virol (2003) 1.05
Varicella-zoster virus latency in human ganglia. Rev Med Virol (2002) 1.04
An update on the treatment of postherpetic neuralgia. J Pain (2008) 1.04
Zoster-associated pain and neural dysfunction. Pain (2001) 1.02
Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician (2000) 1.01
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol (2004) 1.01
Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain (2010) 0.99
Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology (1998) 0.99
Proposed classification of herpes zoster pain. Lancet (1994) 0.99
Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). J Eur Acad Dermatol Venereol (2000) 0.99
Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother (2004) 0.98
Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol (2012) 0.98
Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep (2011) 0.96
Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology (1997) 0.95
Safety and tolerability of zoster vaccine in adults ≥60 years old. Hum Vaccin (2011) 0.95
Cost effectiveness of herpes zoster vaccine in Canada. Pharmacoeconomics (2009) 0.93
Contralateral hemiparesis following herpes zoster ophthalmicus. J Neurol Neurosurg Psychiatry (1985) 0.93
Varicella zoster virus latency. Future Virol (2011) 0.93
Zoster in the elderly: clinical, immunologic and therapeutic considerations. J Am Geriatr Soc (1984) 0.92
Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster. Scand J Infect Dis (2002) 0.92
Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol (2007) 0.91
The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels. Clin Pharmacol Ther (1999) 0.90
Postherpetic neuralgia in the elderly. Int J Clin Pract (2009) 0.90
Safety of Zostavax™--a cohort study in a managed care organization. Vaccine (2012) 0.89
Postherpetic neuralgia. Am Fam Physician (2011) 0.89
The role of stress in the development of herpes zoster and postherpetic neuralgia. Curr Rev Pain (2000) 0.85
Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage (1996) 0.85
A randomized controlled trial of a multifaceted integrated complementary-alternative therapy for chronic herpes zoster-related pain. Altern Med Rev (2012) 0.84
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs. J Am Acad Dermatol (2002) 0.83
Patterns and expenditures of multi-morbidity in an insured working population in the United States: insights for a sustainable health care system and building healthier lives. Popul Health Manag (2013) 0.78
Pharmacological treatment of diabetic peripheral neuropathy. P T (2015) 0.75
Jet lag: current and potential therapies. P T (2011) 0.75
Donepezil 23 mg: a brief insight on efficacy and safety concerns. Consult Pharm (2013) 0.75
Pruritus in the elderly: clinical approaches to the improvement of quality of life. P T (2012) 0.75
Dynamic visual acuity: its place in ophthalmology? Am Orthopt J (2005) 0.75
Treatment of Diabetic Autonomic Neuropathy in Older Adults with Diabetes Mellitus. Consult Pharm (2016) 0.75
Updated Nitrofurantoin Recommendations in the Elderly: A Closer Look at the Evidence. Consult Pharm (2016) 0.75
Development of primary axial myopic anisometropia. Am Orthopt J (2003) 0.75
"Double vision" as a presenting symptom in adults without acquired or long-standing strabismus. Am Orthopt J (2008) 0.75